Total Payments
$5,705
2024 Payments
$45.88
Companies
18
Transactions
159
Medicare Patients
4,529
Medicare Billing
$420,319
Payment Breakdown by Category
Food & Beverage$5,705 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,705 | 159 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $777.47 | 18 | $0 (2020) |
| Abbott Laboratories | $585.98 | 5 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $557.97 | 22 | $0 (2023) |
| Merck Sharp & Dohme LLC | $518.29 | 17 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $508.63 | 22 | $0 (2022) |
| Janssen Pharmaceuticals, Inc | $506.77 | 16 | $0 (2023) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $467.09 | 16 | $0 (2022) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $422.16 | 12 | $0 (2023) |
| Sunovion Pharmaceuticals Inc. | $326.65 | 10 | $0 (2018) |
| Mallinckrodt Enterprises LLC | $220.05 | 2 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $45.88 | 2 | Merck Sharp & Dohme LLC ($45.88) |
| 2023 | $398.25 | 9 | Janssen Pharmaceuticals, Inc ($125.27) |
| 2022 | $1,216 | 25 | Merck Sharp & Dohme LLC ($238.36) |
| 2021 | $521.93 | 24 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) ($128.37) |
| 2020 | $252.99 | 13 | AstraZeneca Pharmaceuticals LP ($78.61) |
| 2019 | $451.00 | 15 | E.R. Squibb & Sons, L.L.C. ($142.20) |
| 2018 | $1,155 | 28 | E.R. Squibb & Sons, L.L.C. ($294.37) |
| 2017 | $1,663 | 43 | E.R. Squibb & Sons, L.L.C. ($323.37) |
All Payment Transactions
159 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/20/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $24.74 | General |
| Category: CARDIOVASCULAR | ||||||
| 03/28/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $21.14 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/09/2023 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $19.89 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/19/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $28.53 | General |
| Category: DIABETES | ||||||
| 06/29/2023 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $22.94 | General |
| Category: CARDIOVASCULAR | ||||||
| 06/21/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $125.27 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/20/2023 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $22.21 | General |
| Category: CARDIOVASCULAR | ||||||
| 03/15/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $20.75 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 03/07/2023 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $25.35 | General |
| Category: CARDIOVASCULAR | ||||||
| 03/01/2023 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $115.23 | General |
| Category: IMMUNOLOGY | ||||||
| 01/17/2023 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $18.08 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/20/2022 | Merck Sharp & Dohme LLC | VERQUVO (Drug) | Food and Beverage | In-kind items and services | $21.72 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/30/2022 | Abbott Laboratories | CARDIOMEMS (Device) | Food and Beverage | In-kind items and services | $134.09 | General |
| Category: Heart Failure | ||||||
| 11/15/2022 | Merck Sharp & Dohme LLC | VERQUVO (Drug) | Food and Beverage | In-kind items and services | $23.03 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/24/2022 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $15.88 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/20/2022 | Merck Sharp & Dohme LLC | VERQUVO (Drug) | Food and Beverage | In-kind items and services | $24.38 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/22/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $19.32 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/21/2022 | Merck Sharp & Dohme LLC | VERQUVO (Drug) | Food and Beverage | In-kind items and services | $123.15 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/19/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $21.06 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/15/2022 | Intuity Medical Inc | Pogo Automatic Blood Glucose Monitoring System (Device) | Food and Beverage | Cash or cash equivalent | $121.22 | General |
| Category: Diabetes | ||||||
| 09/15/2022 | Merck Sharp & Dohme LLC | VERQUVO (Drug) | Food and Beverage | In-kind items and services | $21.82 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/08/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $122.20 | General |
| Category: DIABETES | ||||||
| 09/08/2022 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $19.30 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/08/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $18.88 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/04/2022 | Merck Sharp & Dohme LLC | VERQUVO (Drug) | Food and Beverage | In-kind items and services | $24.26 | General |
| Category: CARDIOVASCULAR | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 1,151 | 1,965 | $167,606 | $83,188 |
| 2022 | 9 | 1,317 | 2,427 | $230,159 | $112,022 |
| 2021 | 9 | 1,080 | 2,091 | $224,846 | $116,756 |
| 2020 | 9 | 981 | 2,245 | $252,829 | $108,354 |
Total Patients
4,529
Total Services
8,728
Medicare Billing
$420,319
Procedure Codes
36
All Medicare Procedures & Services
36 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 86 | 351 | $52,600 | $38,085 | 72.4% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 30 | 236 | $38,364 | $17,051 | 44.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 63 | 140 | $14,000 | $10,349 | 73.9% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 35 | 51 | $15,402 | $6,061 | 39.4% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 535 | 780 | $21,840 | $5,170 | 23.7% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Facility | 2023 | 182 | 183 | $12,627 | $3,118 | 24.7% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2023 | 182 | 183 | $8,418 | $2,083 | 24.7% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 11 | 12 | $2,180 | $887.28 | 40.7% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 27 | 29 | $2,175 | $384.16 | 17.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 94 | 401 | $60,150 | $45,311 | 75.3% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 67 | 419 | $68,113 | $27,740 | 40.7% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 72 | 107 | $32,314 | $13,494 | 41.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 66 | 160 | $16,050 | $12,407 | 77.3% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2022 | 655 | 965 | $27,985 | $6,332 | 22.6% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Facility | 2022 | 154 | 157 | $11,461 | $2,962 | 25.8% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2022 | 154 | 157 | $7,536 | $1,961 | 26.0% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2022 | 14 | 18 | $3,325 | $1,210 | 36.4% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 41 | 43 | $3,225 | $605.71 | 18.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 93 | 463 | $69,150 | $53,668 | 77.6% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 73 | 385 | $62,586 | $25,985 | 41.5% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 84 | 111 | $33,522 | $14,078 | 42.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 77 | 165 | $16,600 | $11,574 | 69.7% |
| 93010 | Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report | Facility | 2021 | 398 | 601 | $16,828 | $4,054 | 24.1% |
| 93016 | Exercise or drug-induced heart and blood vessel stress test with ekg monitoring and physician supervision | Facility | 2021 | 140 | 140 | $9,940 | $2,775 | 27.9% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2021 | 23 | 29 | $5,365 | $1,974 | 36.8% |
About Dr. Leon Mullen, MD
Dr. Leon Mullen, MD is a Cardiovascular Disease healthcare provider based in East Meadow, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/27/2006. The National Provider Identifier (NPI) number assigned to this provider is 1497831986.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Leon Mullen, MD has received a total of $5,705 in payments from pharmaceutical and medical device companies, with $45.88 received in 2024. These payments were reported across 159 transactions from 18 companies. The most common payment nature is "Food and Beverage" ($5,705).
As a Medicare-enrolled provider, Mullen has provided services to 4,529 Medicare beneficiaries, totaling 8,728 services with total Medicare billing of $420,319. Data is available for 4 years (2020–2023), covering 36 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location East Meadow, NY
- Active Since 10/27/2006
- Last Updated 01/14/2014
- Taxonomy Code 207RC0000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1497831986
Products in Payments
- ELIQUIS (Drug) $911.03
- ENTRESTO (Drug) $537.22
- XARELTO (Drug) $506.77
- LifeVest (Device) $467.09
- ACTHAR (Biological) $439.93
- VERQUVO (Drug) $392.71
- JARDIANCE (Drug) $315.95
- FARXIGA (Drug) $283.77
- CARDIOMEMS (Device) $233.30
- Mitra Clip system (Device) $200.79
- Pacemakers (Device) $151.89
- LONHALA MAGNAIR (Drug) $124.95
- SEEBRI (Drug) $124.92
- Pogo Automatic Blood Glucose Monitoring System (Device) $121.22
- BYDUREON (Drug) $119.03
- JANUVIA (Drug) $116.91
- PRALUENT (Drug) $112.23
- PRADAXA (Drug) $106.21
- BRILINTA (Drug) $89.71
- LATUDA (Drug) $76.78
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in East Meadow
Alan Gass, Md, MD
Cardiovascular Disease — Payments: $283,417
Cardiovascular Disease $283,417
Daniel Anghel, Md, MD
Cardiovascular Disease — Payments: $21,645
Cardiovascular Disease $21,645
Dr. Ofek Hai, D.o, D.O
Cardiovascular Disease — Payments: $479.01
Cardiovascular Disease $479.01
Barry Saul, Md, MD
Cardiovascular Disease
Cardiovascular Disease